HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rolf Lewensohn Selected Research

Precision Medicine

1/2020Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rolf Lewensohn Research Topics

Disease

44Neoplasms (Cancer)
10/2022 - 01/2002
30Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 10/2002
15Lung Neoplasms (Lung Cancer)
01/2019 - 06/2004
13Carcinoma (Carcinomatosis)
10/2022 - 01/2002
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2020 - 10/2002
6Neoplasm Metastasis (Metastasis)
01/2022 - 11/2011
5Neutropenia
04/2022 - 12/2015
5Pleural Effusion (Pleural Effusions)
12/2021 - 07/2009
5Adenocarcinoma
11/2021 - 02/2010
5Breast Neoplasms (Breast Cancer)
01/2019 - 05/2003
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 06/2008
4Drug-Related Side Effects and Adverse Reactions
04/2022 - 01/2016
4Thrombocytopenia (Thrombopenia)
01/2020 - 12/2015
3Leukopenia
04/2022 - 01/2020
3Adenocarcinoma of Lung
10/2018 - 07/2009
3Glioma (Gliomas)
12/2017 - 03/2005
3Leukemia
06/2009 - 12/2003
2Melanoma (Melanoma, Malignant)
01/2022 - 08/2021
2Brain Neoplasms (Brain Tumor)
02/2018 - 12/2007
2Tics (Tic)
01/2018 - 08/2014
2Glioblastoma (Glioblastoma Multiforme)
12/2017 - 04/2009
2Ovarian Neoplasms (Ovarian Cancer)
09/2016 - 12/2015
2Multiple Myeloma
06/2013 - 08/2004
2Mitochondrial Diseases (Mitochondrial Disease)
06/2013 - 01/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2010 - 04/2003
2Prostatic Neoplasms (Prostate Cancer)
10/2008 - 06/2008
1Disease Progression
05/2022
1Lung Diseases (Lung Disease)
10/2018
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2018

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
10/2022 - 11/2003
12Biomarkers (Surrogate Marker)IBA
04/2022 - 06/2008
9DNA (Deoxyribonucleic Acid)IBA
02/2021 - 04/2003
7Biological ProductsIBA
01/2019 - 02/2006
6GemcitabineFDA Link
04/2022 - 01/2016
6Pharmaceutical PreparationsIBA
09/2016 - 01/2002
5Carboplatin (JM8)FDA LinkGeneric
04/2022 - 01/2016
5Phosphotransferases (Kinase)IBA
01/2019 - 10/2003
5Melphalan (Alkeran)FDA LinkGeneric
12/2015 - 12/2003
5CaspasesIBA
06/2013 - 01/2002
4MicroRNAs (MicroRNA)IBA
05/2022 - 10/2013
4Tyrosine Kinase InhibitorsIBA
05/2022 - 01/2019
4PlatinumIBA
04/2020 - 09/2015
4Small Interfering RNA (siRNA)IBA
01/2018 - 02/2007
4Cisplatin (Platino)FDA LinkGeneric
01/2018 - 10/2003
4melflufenIBA
09/2016 - 06/2013
3lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
02/2021 - 04/2003
3tyrosine receptor (receptor, tyrosine)IBA
01/2019 - 12/2007
3Alkylating AgentsIBA
09/2016 - 06/2013
3Peptide Hydrolases (Proteases)FDA Link
09/2016 - 07/2003
3ProteomeIBA
02/2010 - 07/2008
3Etoposide (VP 16)FDA LinkGeneric
08/2004 - 10/2002
2Gemtuzumab (Mylotarg)FDA Link
06/2022 - 06/2009
2ErbB Receptors (EGF Receptor)IBA
05/2022 - 01/2019
2EphrinsIBA
02/2021 - 05/2011
2Eph Family Receptors (Eph Receptors)IBA
02/2021 - 09/2016
2Genetic Markers (Genetic Marker)IBA
01/2020 - 01/2020
2Tumor Biomarkers (Tumor Markers)IBA
01/2019 - 01/2018
2DNA-Activated Protein KinaseIBA
01/2018 - 08/2004
2Bleomycin (Blenoxane)FDA LinkGeneric
12/2017 - 08/2007
2TamoxifenFDA LinkGeneric
01/2015 - 10/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2014 - 10/2008
2Insulin-Like PeptidesIBA
08/2014 - 05/2005
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2014 - 04/2009
2ProdrugsIBA
06/2013 - 09/2007
2EnzymesIBA
06/2013 - 07/2003
2DipeptidesIBA
06/2013 - 01/2003
2Peptides (Polypeptides)IBA
07/2009 - 01/2003
2Insulin (Novolin)FDA Link
04/2009 - 12/2007
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2009 - 12/2007
2L-melphalanyl-p-L-fluorophenylalanine ethyl esterIBA
09/2007 - 01/2003
1Caspase 2IBA
06/2022
1osimertinibIBA
05/2022
1AlkanesIBA
04/2022
1Immune Checkpoint InhibitorsIBA
11/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
09/2021
1ErythropoietinFDA Link
02/2021
1Circulating Tumor DNAIBA
02/2021
1P-2 (P 2)IBA
01/2020
1NucleotidesIBA
01/2020
1Anaplastic Lymphoma KinaseIBA
01/2019
1CrizotinibIBA
01/2019
1lorlatinibIBA
01/2019
1locked nucleic acidIBA
01/2019
1ChemokinesIBA
01/2019
1RNA (Ribonucleic Acid)IBA
10/2018
1Carrier Proteins (Binding Protein)IBA
01/2018
1VorinostatFDA Link
01/2018
1EuchromatinIBA
01/2018
1Lysine (L-Lysine)FDA Link
01/2018
1Histones (Histone)IBA
01/2018
1Histone Deacetylases (Histone Deacetylase)IBA
01/2018
1HeterochromatinIBA
01/2018
1trichostatin A (A 300)IBA
01/2018

Therapy/Procedure

18Therapeutics
10/2022 - 01/2002
16Drug Therapy (Chemotherapy)
12/2021 - 01/2002
12Radiotherapy
01/2021 - 04/2003
4Immunotherapy
08/2021 - 01/2018
2Aftercare (After-Treatment)
09/2021 - 10/2002
2Prostatectomy (Retropubic Prostatectomy)
10/2008 - 06/2008
1Precision Medicine
01/2020